Identifying Amnestic Mild Cognitive Impairment in Primary Care: A Feasibility Study

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.31, Iss.7, 2011-07, pp. : 483-491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Systematic Review of Amnestic and Non-Amnestic Mild Cognitive Impairment Induced by Anticholinergic, Antihistamine, GABAergic and Opioid Drugs

By Tannenbaum Cara Paquette Amélie

Drugs & Aging, Vol. 29, Iss. 8, 2012-08 ,pp. : 639-658

Adis International

Access to resources Recommend Favorite

Improved memory with AL 108 in mild cognitive impairment

Inpharma, Vol. 1, Iss. 1651, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

The status of ongoing trials for mild cognitive impairment

By Sramek J.J. Veroff A.E. Cutler N.R.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 741-752

Informa Healthcare

Access to resources Recommend Favorite

A Feasibility Study for Recording of Dispensing Errors and Near Misses in Four UK Primary Care Pharmacies

By Chua S-S. Wong I.C.K.

Drug Safety, Vol. 26, Iss. 11, 2003-01 ,pp. : 803-813

Adis International

Access to resources Recommend Favorite

NMDA Neurotransmission Dysfunction in Mild Cognitive Impairment and Alzheimer’s Disease

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5169-5179

Bentham Science Publishers

Access to resources Recommend Favorite